Triphenylphosphine → 7-(1-Tert-butoxycarbonylpiperidin-4-ylmethoxy)-4-(2-methylindol-5-yloxy)quinazoline

HRID 1791621Notes

Reaction equation

HRID 1791621 reaction equation
[OH:1][C:2]1[CH:11]=[C:10]2[C:5]([C:6]([O:12][C:13]3[CH:14]=[C:15]4[C:19](=[CH:20][CH:21]=3)[NH:18][C:17]([CH3:22])=[CH:16]4)=[N:7][CH:8]=[N:9]2)=[CH:4][CH:3]=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.O[CH2:43][CH:44]1[CH2:49][CH2:48][N:47]([C:50]([O:52][C:53]([CH3:56])([CH3:55])[CH3:54])=[O:51])[CH2:46][CH2:45]1.N(C(OC(C)C)=O)=NC(OC(C)C)=O>C(Cl)Cl>[C:53]([O:52][C:50]([N:47]1[CH2:48][CH2:49][CH:44]([CH2:43][O:1][C:2]2[CH:11]=[C:10]3[C:5]([C:6]([O:12][C:13]4[CH:14]=[C:15]5[C:19](=[CH:20][CH:21]=4)[NH:18][C:17]([CH3:22])=[CH:16]5)=[N:7][CH:8]=[N:9]3)=[CH:4][CH:3]=2)[CH2:45][CH2:46]1)=[O:51])([CH3:56])([CH3:54])[CH3:55]

Participants

6

Procedure

A solution of 7-hydroxy-4-(2-methylindol-5-yloxy)quinazoline (423 mg, 1.45 mmol), (prepared as described for the starting material in Example 82), triphenylphosphine (685 mg, 2.61 mmol), 4-hydroxymethyl-1-tert-butoxycarbonylpiperidine (500 mg, 2.32 mmol), (prepared as described for the starting material in Example 10), and diisopropyl azodicarboxylate (528 mg, 2.61 mmol) in methylene chloride (18 ml) was stirred overnight at ambient temperature. The mixture was then poured onto a column of silica and eluted with ethyl acetate. After evaporation of the solvent, the residue was triturated with ether, filtered, and dried under vacuum to give 7-(1-tert-butoxycarbonylpiperidin-4-ylmethoxy)-4-(2-methylindol-5-yloxy)quinazoline (478 mg, 68%).

Workup

  1. custom(prepared
  2. additionThe mixture was then poured onto a column of silica
  3. washeluted with ethyl acetate
  4. customAfter evaporation of the solvent
  5. customthe residue was triturated with ether
  6. filtrationfiltered
  7. customdried under vacuum

Sources & evidence

ORD record
ord-842f2abcb05746a680def91007ddf757
Source dataset
uspto-grants-2006_07
Patent number
US07074800B1

Reaction notes

Loading…